High Point, NC (March 11, 2004) – Banner Pharmacaps, Inc., global innovator of drug delivery technologies and proprietary health care products, introduces Chewels™, a consumer-preferred chewable gel technology that offers a more palatable dosage form for children. Banner will be highlighting the technology at stand #930 at Vitafoods 2004 in Geneva, Switzerland 11-13 May.
“Chewels™ chewable gels are a smart solution, particularly suitable for pediatric populations because many children are not able to swallow whole tablets or capsules and frequently reject bad-tasting liquids,” says Roger Gordon, PhD, president and CEO of Banner. “With Chewels™, we are aiding parents in being able to take better care of their children.”
A quantitative consumer study conducted in 2002 by Tragon Research shows that Chewels™ are consumer-preferred with three out of four parents sighting they would buy Chewels™ for their children; and two out of three children prefer to take Chewels™ chewable gels verses other forms of medicine administered.
“This patent-pending technology is extremely versatile,” says Dr. Gordon. “The size, shape, color, and flavor of this delivery system can be manipulated to meet our partner’s needs, and subsequently, the consumer’s needs.”
Banner is a global company that researches, develops, and manufactures drug delivery technologies and proprietary health care products. With state-of-the-art, FDA-approved manufacturing facilities and significant investment in research and development, Banner provides innovative oral delivery solutions and unique products to the health care industry worldwide. A wholly owned subsidiary of Sobel N.V., Banner has operations in the United States, Canada, Europe, Latin America and Asia-Pacific.